Kronos Bio
(NASDAQ) KRON
Kronos Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$9.19M
Net Income (TTM)
$64.48M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
KRON News
KRON: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kronos Bio
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Deborah A. Knobelman, PhD
Website
www.kronosbio.comHeadquarters
San Mateo, CA 94402, US
KRON Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-8%
Net Income Margin
-7%
Return on Equity
-52%
Return on Capital
-52%
Return on Assets
-45%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$9.85M
Operating Income
$92.89M
EBITDA
$61.72M
Operating Cash Flow
$65.44M
Capital Expenditure
$4.00K
Free Cash Flow
$65.44M
Cash & ST Invst.
$112.42M
Total Debt
$24.90M
Kronos Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.86M
-26.0%
Gross Profit
$1.52M
-39.8%
Gross Margin
81.33%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$8.36M
+72.1%
EBITDA
$6.15M
+67.1%
Quarterly Fundamentals
Net Cash
$75.64M
-39.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$20.45M
-16.4%
Short Term Debt
$3.64M
-39.7%
Return on Assets
-44.65%
N/A
Return on Invested Capital
-52.18%
N/A
Free Cash Flow
$12.84M
+46.3%
Operating Cash Flow
$12.84M
+46.3%